Skip to content

Carlyle Group Inc. 13F Holdings · Q2 2026

Carlyle Group Inc. reported 19 securities worth $10.00B in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: MDLN (73.78%), SARO (25.30%), PHAT (0.38%). Among its top 25 positions this quarter: 3 new, 2 added, 2 trimmed, 4 exited.

RankTickerCompanyValue% PortfolioSharesAction
1MDLNMedline Inc$7.38B73.78%187.1MHold
2SAROStandardaero Inc$2.53B25.30%84.6MHold
3PHATPhathom Pharmaceuticals Inc$37.9M0.38%3.5MHold
4INVHInvitation Homes Inc$20.0M0.20%662,900Trimmed
5PONYPony Ai Inc$16.4M0.16%2.4MHold
6GETYGetty Images Holdings Inc$5.4M0.05%6.2MHold
7ACETAdicet Bio Inc$1.6M0.02%184,295Hold
8SPRBSpruce Biosciences Inc$2.1M0.02%38,620Hold
9SPWRSunPower Inc$1.6M0.02%2.3MAdded
10DNUTKrispy Kreme Inc$1.2M0.01%340,748Hold
11FWRDForward Air Corp$1.4M0.01%107,214Hold
12NBISNebius Group N.V.$509,8100.01%1,846New
13OKUROnkure Therapeutics Inc$1.2M0.01%269,895Hold
14QTTBQ32 Bio Inc$769,0200.01%60,363Trimmed
15REPXRiley Exploration Permian In$530,3870.01%16,092New
16CUBECubeSmart$00.00%0Exited
17HOODRobinhood Mkts Inc$474,6250.00%4,733Added
18HTFLHeartflow Inc$00.00%0Exited
19JSPRJasper Therapeutics Inc$448,8660.00%1.1MHold
20METCRamaco Res Inc$287,6670.00%21,743New
21NABLN-able Inc$343,9960.00%93,732Hold
22SYRESpyre Therapeutics Inc$00.00%0Exited
23XCURExicure Inc$00.00%0Exited

Source: SEC Form 13F filings · as of 2026-06-30

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR